Cathay Biotech Inc. announced that it has received $28,000,000 in a round of funding co-led by Eight Roads Ventures, Sequoia China Investment Management LLP on November 7, 2022. The transaction included participation from returning investors Source Code Capital, Bits x Bites.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
45.75 CNY | +0.79% |
|
-2.22% | -16.79% |
04-29 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-15 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.79% | 3.63B | |
+11.67% | 1.8B | |
-20.06% | 563M | |
-29.07% | 371M | |
-81.65% | 216M | |
-10.33% | 113M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- Cathay Biotech Inc. announced that it has received $28 million in funding from Eight Roads Ventures, Sequoia China Investment Management LLP, Source Code Capital, Bits x Bites